Decrease in Blood Neutrophil-to-Lymphocyte Ratio Indicates Better Survival After Neoadjuvant Chemotherapy in Patients With Advanced Gastric Cancer
Introduction: Gastric cancer is the fifth most commonly diagnosed tumor and is the fourth leading cause of cancer-related mortality, worldwide. Due to the low rate of early diagnosis, approximately two-thirds of patients are first diagnosed at an advanced stage. Neoadjuvant chemotherapy (NAC) is rec...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2021-11-01
|
| シリーズ: | Frontiers in Surgery |
| 主題: | |
| オンライン･アクセス: | https://www.frontiersin.org/articles/10.3389/fsurg.2021.745748/full |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|